BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 21, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Novel coronavirus SARS-CoV-2

Chembio looks for share of competitive Brazilian market for SARS-CoV-2 tests

Dec. 2, 2020
By Sergio Held
CAJICA, Colombia – Chembio Diagnostic Systems Inc., a point-of-care diagnostic company focused on infectious diseases, received the approval from Anvisa, the Brazilian health care surveillance agency, to distribute its tests in the Latin American market. The approval adds yet another test to the hundreds already approved in Brazil, where the market for such tests is quickly getting crowded sending prices down. Brazil is one of the countries most affected by COVID-19 with almost 6 million cases and 166,000 deaths, the third highest number of cases in the world.
Read More

Bluestar Genomics, University of Chicago see publication of 5hmC map

Dec. 2, 2020
By Liz Hollis
Bluestar Genomics Inc. and the University of Chicago revealed the publication of a genome-wide 5-hydroxymethylcytosine (5hmC) map across multiple human tissue types. In the report, published Dec. 2, 2020, in Nature Communications, the researchers detailed the development of the map by characterizing the genomic distributions of 5hmC in 19 human tissues derived from 10 organ systems.
Read More
Lumipulse system

Fujirebio Diagnostics seeks FDA clearance of Alzheimer’s disease test

Dec. 2, 2020
By Meg Bryant
Recent advances in biomarkers and imaging capabilities have improved the diagnosis of Alzheimer’s disease (AD). Fujirebio Diagnostics Inc. aims to further expand the arsenal of AD diagnostics with its Lumipulse G β-Amyloid Ratio (1-42/1-40) in vitro diagnostic test. On Wednesday, the company said it had filed a 510(k) submission with the U.S. FDA for premarket clearance of the Lumipulse G β-Amyloid IVD.
Read More

Regulatory actions for Dec. 2, 2020

Dec. 2, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Etiometry, Modulim, Nico.Lab, Roche, University of California.
Read More

Other news to note for Dec. 2, 2020

Dec. 2, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: A&E Medical, Becton Dickinson, Bio-Techne, Centurion Service Group, Chan Zuckerberg Initiative, Cortechs.ai, Cortechs Labs, Cyduct Diagnostics, Etruenorth, Exactech, Fairwarning Technologies, Fastercures, Healthware Group, Hhc Preferred, Imprivata, Lifelabs Medical Laboratory Services, Milken Institute, Mivi Neuroscience, Motus GI, Muvr Labs, Oxford Immunotec, Renalytix AI, Riken Genesis, Regulus Therapeutics, Rsa Biomedical, Sectra, Thrive Health, Tng Dx, Trimedx, Zimmer Biomet.
Read More

In the clinic for Dec. 2, 2020

Dec. 2, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cognita Labs, Nanovibronix.
Read More

Financings for Dec. 2, 2020

Dec. 2, 2020
Med-tech firms raising money in public or private financings, including: Assure Holdings, Kayentis, Nanovibronix, Segmed.
Read More

Appointments and advancements for Dec. 2, 2020

Dec. 2, 2020
New hires and promotions in the med-tech industry, including: Alchemy 43, American College of Cardiology, Carterra, Deep Lens, N2 Biomedical, Proprio, V-Wave.
Read More
Regulatory front

CMS posts final coverage memos for VADs, artificial hearts

Dec. 2, 2020
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA slaps two companies for illicit COVID offerings; FDA approves new PET imaging agent for prostate cancer.
Read More

BioWorld MedTech’s Orthopedics Extra for Dec. 2, 2020

Dec. 2, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Researchers develop new biomaterial that helps bones heal faster; Obesity increases the risk of early hip fracture in postmenopausal women; Vitamin D regulates calcium in intestine differently than previously thought.
Read More
Previous 1 2 … 1330 1331 1332 1333 1334 1335 1336 1337 1338 … 10248 10249 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 21, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Microscopic view of the ebola virus

    WHO declares Ebola outbreak a public health emergency of international concern

    BioWorld
    The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing